handheld devices for high viscosity injectables   Deuterated Drugs • Published August 2017  •  No. DTR354K  •  Price US $3,850


Deuterated Drugs: Products, Pipelines, Strategies, Therapeutics and Markets is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the healthcare sector. The study is designed to provide drug company decision makers, drug formulation developers, product designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, disease segments, and commercial opportunities for drugs that incorporate deuterium into the chemical structure of APIs to modify drug properties in vivo. Provider organization business managers, healthcare administrators and investors will also benefit from this study.

 

Bar_Graph  Report Brochure (Download PDF)

Blue document  Report Order Form (Download PDF)


Deuterated Drugs – What You Will Learn

• What deuterated drugs are currently FDA-approved or in late-stage development, what are their distinguishing properties, how are they marketed, and what are the therapeutic specifics?
• What are the major factors driving the development of deuterated drugs?
• What are the product strategies of deuterated drug developers?
• What is the size of the deuterated drug market today, who are the active sector participants, and what will the market look like in 2024?
• How important are formulator-developer-manufacturer relationships and what are the key alliances in the industry?
• What are the significant economic, technology, and regulatory factors affecting the market for deuterated drugs?


Deuterated Drugs – Summary of Contents

 

Executive Summary

 

Drug Therapy Market Dynamics

Market Segments and Indications

Competing Technologies

Market Drivers

Drug Re-positioning/Re-purposing

Extending Patent Life

Dosing Frequency & Patient Adherence

Competitive Landscape

Formulators/Developers

Marketers

Alliances

Acquisitions

 

Deuterated Drug Therapeutics

 

Formulation Technology

Drug Property Kinetics

Extending Dosing Intervals

Addressing Unmet Therapeutic Needs

 

Selected Near-term Therapeutic Targets

 

Neurotransmitter Regulation

Transmembrane Conductance

Kinase Inhibitors

Anti-inflammatory

Mitochondrial Function Modulation

Antineoplastic

 

Deuterated Drugs – Near-term Therapeutic Market Analysis     

 

Addiction

Autoimmune Diseases

Hereditary

Neurology

Oncology

Ophthalmology

 

Market Factors

 

Regulations and Approvals

Clinical Trials & End Points

IP/Patent Factors

Defensive Patent Strategies

Healthcare Economics

 

Company Profiles